Savara (SVRA) Misses Q1 EPS by 52c

Savara (NASDAQ: SVRA) reported Q1 EPS of ($0.88), $0.52 worse than the analyst estimate of ($0.36).

• AeroVanc Phase 3 AVAIL study enrollment on track for completion in Q1 2019
• First patient enrolled in Molgradex IMPALA-X safety extension study

For earnings history and earnings-related data on Savara (SVRA) click here.

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• AppLovin drops 3% as Edgewater analyst warns of stalled market share growth
• On Holding AG (ONON) Stock: Market Doesn't Appreciate Brand's Potential, Says Analyst